VIASYS Healthcare Inc. Acquires Tiara Medical Systems, Inc.; Acquisition Expands VIASYS' Presence in Sleep Therapy

Randy Thurman, Chairman, President and Chief Executive Officer,VIASYS Healthcare Inc., commented, "The acquisition of Tiara Medicalreflects our commitment to expand our presence in the sleep therapymarket. VIASYS is a leading global competitor in pulmonary,neurological and sleep diagnostics, as well as within the criticalcare segment. We believe that this acquisition positions us to competeeffectively in this rapidly growing market segment by building on ourexisting product offering. In addition, we believe that our access tothe decision makers in the sleep therapy market, our existing presencein this market, and our international sales and distributioncapability will allow us to increase sales of the Tiara products."

Based in Oak Forest, Illinois, Tiara Medical designs,manufactures, markets, and sells Continuous Positive Airway Pressure(CPAP) masks, headgear, circuits, and filters. These products arecomplemented by a comprehensive product line of specialty filters andaccessories for oxygen concentrators and mechanical ventilators. TiaraMedical offers home health care providers the convenience of acomprehensive range of products to meet the needs of patientsreceiving treatment for Obstructive Sleep Apnea (OSA) and otherchronic respiratory diseases. Tiara Medical recently introduced TheAdvantage Series(TM) Full Face Mask and the Snapp-X(TM) Direct NasalInterface.

Ed Pulwer, Group President, VIASYS Respiratory Care, commented onthe acquisition, "With the acquisition of Tiara Medical, VIASYS isincreasing its presence in the global sleep therapy market. Accordingto Frost and Sullivan, sleep therapy is the fastest growing marketsegment in the global respiratory market. VIASYS is already a marketleader in the sleep diagnostics business, with well-established brandssuch as Jaeger(TM) and SENSORMEDICS(R). We believe that TiaraMedical's expertise in CPAP and non-invasive ventilation mask designwill enhance the VIASYS global product offering. We believe thisacquisition is a key step following the establishment earlier thisyear of the VIASYS Sleep Division as a separate operating entityfocused on this opportunity. Rebecca Mabry, General Manager, SleepDiagnostics and Therapy, will be responsible for integrating thisacquisition into VIASYS."

James Fitzsimmons, President and Chief Executive Officer, TiaraMedical, commented, "The combined product offering of VIASYSHealthcare and Tiara Medical will offer sleep diagnostics laboratoriesand home healthcare providers a variety of choices in the diagnosisand treatment of sleep disorders. We also expect that VIASYS' globaldistribution and product support infrastructure will greatly enhanceTiara Medical's ability to penetrate domestic and internationalmarkets for sleep diagnostic and therapeutic devices."

Under the terms of the acquisition agreement, VIASYS acquired allof the outstanding stock of Tiara Medical through one of itssubsidiaries for consideration of approximately $24.3 million. VIASYSfinanced the acquisition with cash and borrowings under its revolvingcredit facility. Tiara's 2005 revenues were $10.3 million, and thecompany has grown approximately 15% compounded over the last threeyears.

ABOUT VIASYS HEALTHCARE INC.

VIASYS Healthcare Inc. is a global, research-based medicaltechnology company focused on respiratory, neurology, medicaldisposable and orthopedic products. VIASYS products are marketed underwell-recognized trademarks including, among others, AVEA(R), BEAR(R),BIRD(R), CORFLO(R), CORPAK(R), CORTRAK(R), EME(R), GRASON-STADLER(R),JAEGER(TM), LYRA(R), MEDELEC(R), MICROGAS(R), NAVIGATOR(R),NICOLET(R), NicoletOne(TM), PULMONETIC(TM), SENSORMEDICS(R), TECA(R),TECOMET(TM), VELA(R) and VMAX(R). VIASYS is headquartered inConshohocken, PA, and its businesses are conducted through itsRespiratory Care, NeuroCare, MedSystems and Orthopedics businessunits. More information can be found athttp://www.viasyshealthcare.com.

ABOUT TIARA MEDICAL SYSTEMS, INC.

Tiara Medical designs, manufactures, and markets CPAP masks,headgear, filters and respiratory accessories for use in home healthcare. Tiara Medical is headquartered in Oak Forest, Illinois. Moreinformation can be found at http://www.tiaramed.com.

This news release includes forward-looking statements within themeaning of the "Safe Harbor" provisions of Private SecuritiesLitigation Reform Act of 1995 regarding VIASYS' product offering,VIASYS' ability to compete in the sleep market, VIASYS' ability toincrease the sales of the Tiara Medical products domestically andinternationally, VIASYS' presence in and commitment to the sleeptherapy market, the effect of VIASYS' distribution and supportinfrastructure on Tiara Medical's ability to penetrate markets, thestrategic impact of acquiring Tiara Medical, and the marketopportunity in sleep therapy. These forward-looking statements arebased on current expectations and involve inherent risks anduncertainties, including important factors that could delay, divert,or change the expectations for VIASYS' products and could cause actualoutcomes and results to differ materially from current expectations.These factors include, among other things, market factors, internalresearch and development initiatives, partnered research anddevelopment initiatives, competitive and new product development,marketing initiatives, sales and distribution risks, the continuedgrowth of the sleep therapy market, governmental regulations andlegislation, patent positions and litigation. For further details anda discussion of other risks and uncertainties that may change VIASYS'expectations, please see VIASYS' annual report on Form 10-K for theyear ended January 1, 2006, which is on file with the Securities andExchange Commission. VIASYS undertakes no obligation to publiclyupdate this forward-looking statement, whether as a result of newinformation, future events, or otherwise.